John J. Albers focuses on Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Apolipoprotein B. His study in Internal medicine is interdisciplinary in nature, drawing from both Acyltransferase and Hyperlipidemia. The Cholesterol study combines topics in areas such as Human plasma, Chromatography and Apolipoprotein E.
His Lipoprotein study incorporates themes from Coronary heart disease, Polyacrylamide gel electrophoresis, Chronic hemodialysis and Myocardial infarction. The concepts of his Apolipoprotein B study are interwoven with issues in Gene isoform, Radial immunodiffusion and Population sample. He interconnects Simvastatin and Laropiprant in the investigation of issues within Niacin.
His main research concerns Internal medicine, Endocrinology, Cholesterol, Lipoprotein and Apolipoprotein B. His Internal medicine study integrates concerns from other disciplines, such as Hyperlipidemia and Cardiology. His study in the field of Very low-density lipoprotein, Triglyceride and Low-density lipoprotein also crosses realms of Phospholipid transfer protein.
His biological study spans a wide range of topics, including Chromatography and Lecithin. Lipoprotein is a subfield of Biochemistry that John J. Albers studies. His Apolipoprotein B research is multidisciplinary, relying on both Radioimmunoassay and Radial immunodiffusion.
His scientific interests lie mostly in Internal medicine, Phospholipid transfer protein, Endocrinology, Lipoprotein and Cholesterol. His research in Internal medicine focuses on subjects like Cardiology, which are connected to Gastroenterology and Homocysteine. His work deals with themes such as Cerebrospinal fluid and Case-control study, which intersect with Endocrinology.
His work carried out in the field of Lipoprotein brings together such families of science as Diabetes mellitus, Computational biology and Bioinformatics. His Cholesterol study focuses on High-density lipoprotein in particular. The Apolipoprotein B study combines topics in areas such as Cellulose and Distribution.
Internal medicine, Endocrinology, Phospholipid transfer protein, Lipoprotein and Cholesterol are his primary areas of study. His research investigates the connection between Internal medicine and topics such as Cardiology that intersect with problems in Gastroenterology. When carried out as part of a general Endocrinology research project, his work on Apolipoprotein B, Simvastatin and Low-density lipoprotein is frequently linked to work in Human brain, therefore connecting diverse disciplines of study.
His work in the fields of Apolipoprotein B, such as Lipoprotein, intersects with other areas such as Hazard ratio. John J. Albers interconnects Diabetes mellitus, High-density lipoprotein and Serum samples in the investigation of issues within Lipoprotein. His High-density lipoprotein research integrates issues from Acute coronary syndrome and Myocardial infarction.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
Greg Brown;John J. Albers;Lloyd D. Fisher;Susan M. Schaefer.
The New England Journal of Medicine (1990)
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
Brown Bg;Zhao Xq;Chait A;Fisher Ld.
The New England Journal of Medicine (2001)
Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial
Valery T. Miller;John LaRosa;Vanessa Barnabei;Craig Kessler.
A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol.
G R Warnick;J J Albers.
Journal of Lipid Research (1978)
Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease.
B. G. Brown;Xue-Qiao Zhao;D. E. Sacco;J. J. Albers.
Characterization of lipoprotein particles isolated by immunoaffinity chromatography. Particles containing A-I and A-II and particles containing A-I but no A-II.
M C Cheung;J J Albers.
Journal of Biological Chemistry (1984)
The Measurement of Apolipoprotein A-I and A-II Levels in Men and Women by Immunoassay
Marian C. Cheung;John J. Albers.
Journal of Clinical Investigation (1977)
Increased exercise level and plasma lipoprotein concentrations: A one-year, randomized, controlled study in sedentary, middle-aged men
Peter D. Wood;William L. Haskell;Steven N. Blair;Paul T. Williams.
Metabolism-clinical and Experimental (1983)
Quantitation of apolipoprotein A-I of human plasma high density lipoprotein
John J. Albers;Patricia W. Wahl;Veneracion G. Cabana;William R. Hazzard.
Metabolism-clinical and Experimental (1976)
Isolation and characterization of human plasma lipid transfer proteins.
J J Albers;J H Tollefson;C H Chen;A Steinmetz.
Arteriosclerosis, Thrombosis, and Vascular Biology (1984)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: